InvestorsHub Logo
Followers 1
Posts 521
Boards Moderated 0
Alias Born 08/16/2017

Re: None

Thursday, 10/19/2017 4:10:47 PM

Thursday, October 19, 2017 4:10:47 PM

Post# of 80866
Financially Illiterate investors here don't realize Amerop's $18m number is not for working capital or anything that helps the day-to-day ops of MusclePharm. Fiduciary Duty doesn't even come into play.

Amerop is holding $4.5m of unsecured worthless shares and is trying to salvage that investment by expressing interest in buying Ryan's secured shares (think preferred shares for you investors with a remedial knowledge).

Amerop simply is interested in "swapping places" with Ryan and Ryan is not obligated to even respond.

Think I can go to Facebook BOD and say I want all Zuckerberg's shares and am willing to pay what he paid. There is no Fiduciary Duty there.

Ryan's shares actually have value as they grant 1st lien on all MusclePharm assets in case of default.

Buck's shares have zero value and he want's Ryan's deal but he is not entitled.

I don't know if Buck felt he had some sort of tacit agreement with Ryan when he bought the Arnold settlement shares in a private transaction and now sees they are worthless with the distressed operating situation MusclePharm finds itself in.

Either Buck got screwed on a handshake deal with Ryan or Buck is the dumbest investor in the world.

It is 50/50 in my opinion.